RHUDEX
Dead / Cancelled — Cancelled — Section 8 (as of 28 Sept 2012)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78285532
- Registration number
- 2943640
- Mark type
- Word mark
- Filed
- 11 Aug 2003
- Published for opposition
- 01 Feb 2005
- Registered
- 26 Apr 2005
- Attorney of record
- Purvi J. Patel
Goods and services
- Class 005 — Pharmaceuticals: Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics
- Class 010 — Medical apparatus: Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors, syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
- Class 042 — Scientific and technological services: Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property namely, trademarks and patents in the field of biotechnology
Owner
- MEDIGENE LIMITED, OXFORDSHIRE, GB
- Avidex Limited, Oxfordshire, GB
- Avidex Limited, Oxfordshire, GB
- Avidex Limited, Oxfordshire, GB
Prosecution history
- 28 Sept 2012 — CANCELLED SEC. 8 (6-YR)
- 17 Dec 2008 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2008 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Sept 2007 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Apr 2005 — REGISTERED-PRINCIPAL REGISTER
- 01 Feb 2005 — PUBLISHED FOR OPPOSITION
- 12 Jan 2005 — NOTICE OF PUBLICATION
- 30 Nov 2004 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 29 Nov 2004 — ASSIGNED TO LIE
- 21 Nov 2004 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Aug 2004 — AMENDMENT FROM APPLICANT ENTERED
- 05 Aug 2004 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Aug 2004 — Sec. 1(B) CLAIM DELETED
- 05 Aug 2004 — PAPER RECEIVED
- 03 Feb 2004 — NON-FINAL ACTION MAILED